Odyssey Therapeutics is the latest startup formed by serial biotech entrepreneur Gary Glick. Odyssey’s destination is oncology and immunology drugs that address novel disease targets, and the biotech now has $218 million in Series A financing to fuel the journey.
Antique toolbox: Can you identify this month's mystery tool from Landis Valley Museum? lancasteronline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lancasteronline.com Daily Mail and Mail on Sunday newspapers.
A well-funded cancer drug startup brings on GSK's Axel Hoos as CEO biopharmadive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biopharmadive.com Daily Mail and Mail on Sunday newspapers.